Gordon Ramsay slams restaurants creating special Ozempic menus for weight loss drug users, calling the trend 'absolute bulls- ...

Insurance data reveals dramatic regional differences in Ozempic and Mounjaro usage, with obesity-heavy states prescribing GLP ...

Economist Emily Oster joins Michael Smerconish to discuss the growing debate over whether Medicare and Medicaid should cover ...

The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, ...

Ever watchful, skincare brands are eyeing their new frontier. Early pioneers—three, to be exact—have formulated serums to ...

Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

For decades, bodybuilders and biohackers quietly experimented with peptides in underground forums and gym locker rooms. Then ...

As can dietary fibers. A systematic review and meta-analysis published in September 2025 found that dietary fiber supplements ...

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Hansal Mehta says that health concerns have been moralised in current times, where we call it ‘discipline’ when a person suffers silently.